Basilea Pharmaceutica Aktie
42,25
EUR
+0,90
EUR
+2,18
%
40,70
CHF
+0,45
CHF
+1,12
%
Werbung
Basilea Pharmaceutica Aktie Analyse
10.12.12 | Basilea Pharmaceutica buy | Sarasin Research | |
16.08.12 | Basilea Pharmaceutica buy | Sarasin Research | |
12.06.12 | Basilea Pharmaceutica buy | Sarasin Research | |
12.03.12 | Basilea Pharmaceutica buy | Sarasin Research | |
09.02.12 | Basilea Pharmaceutica buy | Sarasin Research | |
05.01.12 | Basilea Pharmaceutica buy | Sarasin Research | |
07.10.11 | Basilea Pharmaceutica buy | Citigroup Corp. | |
20.06.11 | Basilea Pharmaceutica buy | Citigroup Corp. | |
Werbung
|
|||
27.08.10 | Basilea Pharmaceutica buy | Vontobel Research | |
09.04.09 | Basilea Pharmaceutica | Fuchsbriefe | |
06.11.08 | Basilea Pharmaceutica | Focus Money | |
22.03.07 | Basilea Pharmaceutica | Der Aktionär | |
13.03.07 | Basilea Pharmaceutica | Biotech-Report | |
03.02.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
13.01.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston |
Werbung
Werbung